1-12 of 12
Judith Feucht
Close
Sort by
Journal Articles

Novel extragenic genomic safe harbors for precise therapeutic T-cell engineering

Ashlesha Odak, Han Yuan, Judith Feucht, Vito Adrian Cantu, Jorge Mansilla-Soto, Friederike Kogel, Justin Eyquem, John Everett, Frederic D. Bushman, Christina S. Leslie, Michel Sadelain
Journal: Blood
Blood (2023) 141 (22): 2698–2712.
https://doi.org/10.1182/blood.2022018924
Published: 2023
Includes: Supplemental data
Journal Articles

Loss of TET2 Uncouples Proliferative and Effector Functions in CAR T Cells

Nayan Jain, Zeguo Zhao, PhD, Archana S. Iyer, PhD, Michael Lopez, Judith Feucht, MD, Richard P. Koche, PhD, Yingqian Zhan, Michel Sadelain, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-142957
Published: 2020
Journal Articles

Targeted Integration of a CAR at a Novel Genomic Safe Harbor Directs Potent Therapeutic Outcomes

Ashlesha Odak, MS, Han Yuan, PhD, Judith Feucht, MD, Jorge Mansilla - Soto, PhD, Justin Eyquem, PhD, Christina Leslie, PhD, Michel Sadelain, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28.
https://doi.org/10.1182/blood-2020-141967
Published: 2020
Journal Articles

Pluripotent Cell-Derived Off-the-Shelf TCR-Less CAR-Targeted Cytotoxic T Cell Therapeutic for the Allogeneic Treatment of B Cell Malignancies

Raedun Clarke, PhD, Sjoukje Van Der Stegen, PhD, Chia-Wei Chang, PhD, Mushtaq Husain, PhD, Yi-Shin Lai, PhD, Eigen Peralta, PhD, Laurel Stokely, Ramzey Abujarour, PhD, Jason Dinella, PhD, Tom Lee, PhD, Mochtar Pribadi, PhD, Helen Chu, PhD, Chris Truong, Mohsen Sabouri-Ghomi, PhD, Miguel Meza, BS, Judith Feucht, MD, Justin Eyquem, PhD, Jorge Mansilla-Soto, PhD, Isabelle Riviere, PhD, Michel Sadelain, MD PhD, Bahram Valamehr, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4546.
https://doi.org/10.1182/blood-2018-99-116843
Published: 2018
Journal Articles

Prophylaxis of Chemotherapy-Induced Nausea and Vomiting with Fosaprepitant and Granisetron in Pediatric Patients after Allogeneic HSCT

Karin Melanie Cabanillas Stanchi, MSc, Julia Vek, Dr. MD, Patrick Schlegel, MD, Christian M. Seitz, MD, Joachim Rupprecht, Dr. MD, Sarah Schober, Dr. MD, Sebastian Michaelis, Dr. MD, Carmen Malaval, Dr. MD, Tim Flaadt, Dr. MD, Lukas Schnaufer, Dr. MD, Manon Queudeville, Dr. MD, Judith Feucht, Dr. MD, Peter Lang, MD, Rupert Handgretinger, MD PhD, Michaela Döring, Dr. MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3388.
https://doi.org/10.1182/blood-2018-99-112762
Published: 2018
Journal Articles

Calibrated CAR Activation Potential Directs Alternative T Cell Fates and Therapeutic Potency

Judith Feucht, MD, Jie Sun, PhD, Justin Eyquem, PhD, Yu-Jui Ho, PhD, Zeguo Zhao, PhD, Josef Leibold, MD, Anton Dobrin, Annalisa Cabriolu, PhD, Mohamad Hamieh, PhD, Michel Sadelain, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1412.
https://doi.org/10.1182/blood-2018-99-117698
Published: 2018
Journal Articles

Defined Central Memory and Stem Memory T Cell Phenotype of CD4 and CD8 CAR T Cells for the Treatment of CD19+ Acute Lymphoblastic Leukemia in an Automated Closed System

Franziska Blaeschke, MD, Theresa Kaeuferle, PhD, Judith Feucht, MD, Dana Weber, Ramin Lotfi, MD, Andrew Kaiser, PhD, Mario Assenmacher, PhD, Michaela Doering, MD, Tobias Feuchtinger, MD
Journal: Blood
Blood (2016) 128 (22): 4558.
https://doi.org/10.1182/blood.V128.22.4558.4558
Published: 2016
Journal Articles

Leukemia Related Co-Stimulation / Co-Inhibition Predict T-Cell Attack of Acute Lymphoblastic Leukemia Mediated By Blinatumomab

Tobias Feuchtinger, MD, Judith Feucht, MD, Simone Kayser, David Gorodezki, Michaela Döring, MD, Franziska Blaeschke, MD, Hans Bösmüller, MD, Leticia Quintanilla-Fend, Prof. Dr., Patrick Schlegel, MD, Martin Ebinger, Peter J. Lang, MD, Rupert Handgretinger, MD
Journal: Blood
Blood (2015) 126 (23): 3764.
https://doi.org/10.1182/blood.V126.23.3764.3764
Published: 2015
Journal Articles

Pharmacokinetic Analysis during Antifungal Prophylaxis with Posaconazole Suspension in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Michaela Döring, MD, Karin Melanie Cabanillas Stanchi, Manon Queudeville, MD, Judith Feucht, MD, Patrick Schlegel, MD, Tobias Feuchtinger, MD, Peter Lang, MD, Rupert Handgretinger, Prof. MD, Werner J. Heinz, MD
Journal: Blood
Blood (2015) 126 (23): 4338.
https://doi.org/10.1182/blood.V126.23.4338.4338
Published: 2015
Journal Articles

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

Clinical Trials & Observations
Judith Feucht, Kathrin Opherk, Peter Lang, Simone Kayser, Lena Hartl, Wolfgang Bethge, Susanne Matthes-Martin, Peter Bader, Michael H. Albert, Britta Maecker-Kolhoff, Johann Greil, Hermann Einsele, Paul-Gerhardt Schlegel, Friedhelm R. Schuster, Bernhard Kremens, Claudia Rossig, Bernd Gruhn, Rupert Handgretinger, Tobias Feuchtinger
Journal: Blood
Blood (2015) 125 (12): 1986–1994.
https://doi.org/10.1182/blood-2014-06-573725
Published: 2015
Includes: Supplemental data
Journal Articles

Detection of Th1 Driven T-Cell Responses in Peripheral Could Guide Individualized Immunosuppression and Risk of Viral Reactivation Under GvHD Prophylaxis Following Allogeneic Stem Cell Transplantation.

Judith Feucht, Kathrin Opherk, Cornelia Neinhaus, Simone Kayser, Wolfgang A. Bethge, MD, Rupert Handgretinger, MD, Peter Lang, MD, Tobias F. Feuchtinger, MD
Journal: Blood
Blood (2012) 120 (21): 3047.
https://doi.org/10.1182/blood.V120.21.3047.3047
Published: 2012
Journal Articles

Transient but Reversible Activation Defect of T-Cell Responses Against Cytomegalovirus and Adenovirus through Immunosuppresion with Calcineurin Inhibitors.

Cornelia Neinhaus, Kathrin Opherk, Simone Kayser, Joseph Leibold, Judith Feucht, Peter Lang, Rupert Handgretinger, MD, PhD, Tobias F. Feuchtinger, MD
Journal: Blood
Blood (2010) 116 (21): 4542.
https://doi.org/10.1182/blood.V116.21.4542.4542
Published: 2010